Persistent AKT activation supports HCC progression by inhibiting apoptosis, enhancing cell survival through phosphorylation of transcription factors such as c‐Myc and NF‐κB, which accelerates cell cycle and tumor growth [422, 423]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.